BioLineRx Ltd.

(BLRX) Trade

By |

Profile

BioLine Rx Ltd is a clinical-stage biopharmaceutical company, which is engaged in the development of therapeutics, from preclinical-stage development to advanced clinical trials, for a range of medical needs. It offers products such as BL-1020 which is used to improve cognitive function in schizophrenia patients; BL-1040 for the prevention of cardiac remodeling following an acute myocardial infarction; BL-5010, for non-surgical removal of skin lesions; BL-1021 for the treatment of neuropathic pain or pain that results from damage to nerve fibers, and BL-7040, a synthetic oligonucleotide, which is used for the treatment of inflammatory bowel disease. Geographically all the operations are functioned from the region of Israel.

Contact Information

Website: www.biolinerx.com
Email: IR@biolinerx.com
Main Phone: +972 86429100
Address: 2 HaMa'ayan Street
City / Town: Modi'in
Country: ISR
Postal Code: 7177871

Issuer Information

Exchange: NSC
CEO: Philip Serlin
Employees: 51
$ 0.66 $ 0.0099 (1.51%)
Last Price 0.66 Change $ 0.0099 Change % 1.51 Tick N/A
Bid 0.62 Bid Size 500.00 Ask 0.67 Ask Size 5,000.00
Open 0.66 High 0.67 Low 0.64 Prev Close 0.66
Last Trade Volume 410,009 52 Wk Hi 1.84 52 Wk Low 0.64
Market Cap 75.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 114,188,010.00 EPS (TTM) -0.24 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 4 4 4 4
Low Target Price Estimate 2 2 2 2
Mean Target Price Estimate 3 3 3 3
Standard Deviation 1 1 1 1
Date of Most Recent Estimate 04/05/18 04/05/18 04/05/18 04/05/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1